Cargando…
Cardiovascular Risk Factors: It's Time to Focus on Variability!
Atherosclerotic heart disease remains a leading cause of morbidity and mortality worldwide. While extensive research supports cardiovascular risk factor reduction in the form of achieving evidence-based blood pressure, lipid, glucose, and body weight targets as a means to improve cardiovascular outc...
Autores principales: | Barnett, Mallory P., Bangalore, Sripal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Lipidology and Atherosclerosis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379092/ https://www.ncbi.nlm.nih.gov/pubmed/32821735 http://dx.doi.org/10.12997/jla.2020.9.2.255 |
Ejemplares similares
-
Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
por: Devabhaktuni, Madhuri, et al.
Publicado: (2009) -
Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019
por: Aggarwal, Gaurav, et al.
Publicado: (2020) -
The State of Coronary Thrombus Aspiration
por: Pruthi, Sonal, et al.
Publicado: (2022) -
Impact of Sex and Contact‐to‐Device Time on Clinical Outcomes in Acute ST‐Segment Elevation Myocardial Infarction—Findings From the National Cardiovascular Data Registry
por: Roswell, Robert O., et al.
Publicado: (2017) -
Cardiovascular and Venous Thromboembolic Risk With Janus Kinase Inhibitors in Immune‐Mediated Inflammatory Diseases: A Systematic Review and Meta‐Analysis of Randomized Trials
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2022)